pre-treatment with anti-emetics 30 minutes prior is the documented mitigation
Companies such as Novo Nordisk and Eli Lilly continue to lead the market with their innovative GLP-1 receptor agonists, contributing to a surge in global sales
The relationship appears dose-dependent and duration-dependent, with longer treatment periods carrying incrementally higher risk
These FDA-approved medications work by regulating appetite, slowing gastric emptying, and improving insulin sensitivity, making it easier to maintain a healthy caloric deficit
Long-Term Commitment: Ozempic is typically prescribed for chronic use
Peer review Peer review information Nature Communications thanks Cristina Al-Khalili Szigyarto and the other, anonymous, reviewers for their contribution to the peer review of this work